Jeff Yass’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.13M Buy
83,470
+75,472
+944% +$2.27M ﹤0.01% 6114
2026
Q2
$211K Sell
7,998
-230,500
-97% -$5.33M ﹤0.01% 11827
2026
Q1
$5.36M Buy
238,498
+120,342
+102% +$2.23M ﹤0.01% 4108
2025
Q4
$2.1M Sell
118,156
-37,520
-24% -$472K ﹤0.01% 5559
2025
Q3
$626K Buy
155,676
+94,613
+155% +$314K ﹤0.01% 8457
2025
Q2
$134K Buy
61,063
+33,061
+118% +$78.7K ﹤0.01% 11590
2025
Q1
$60.5K Sell
28,002
-12,924
-32% -$46.3K ﹤0.01% 11795
2024
Q4
$173K Buy
+40,926
New +$255K ﹤0.01% 10884

Other funds holding ANRO

Jeff Yass's ANRO Position: Q3 2026 in Review

Jeff Yass increased its Alto Neuroscience (ANRO) stake by 944% in Q3 2026, buying an estimated $2.27M and bringing the position to 83,470 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #6114.

Jeff Yass first reported a position in ANRO in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.36M in Q1 2026. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Jeff Yass held 83,470 shares of Alto Neuroscience worth $2.13M as of Q3 2026.
  • Jeff Yass bought 75,472 Alto Neuroscience shares in Q3 2026, an estimated $2.27M.
  • Alto Neuroscience made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6114 holding.
  • Jeff Yass first reported a position in Alto Neuroscience in Q4 2024 and has held it in 8 quarters since.
  • Jeff Yass's Alto Neuroscience position peaked at $5.36M in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.